Bond Celgen Corporation 3.875% ( US151020AS39 ) in USD

Issuer	Celgen Corporation
Market price	102.101 % ⇌
Country	United States
ISIN code	US151020AS39 ( in USD )
Interest rate	3.875% per year ( payment 2 times a year)
Maturity	14/08/2025
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible
Minimal amount	2 000 USD
Total amount	2 500 000 000 USD
Cusip	151020AS3
Standard & Poor's ( S&P ) rating	A+ ( Upper medium grade - Investment-grade )
Moody's rating	N/A
Next Coupon	15/08/2025 ( In 42 days )
Detailed description	Celgene Corporation was a biopharmaceutical company acquired by Bristol Myers Squibb in 2019, known for its development and commercialization of cancer therapies and other immunology treatments. Celgene Corp. issued a USD 2,500,000,000 bond (ISIN: US151020AS39, CUSIP: 151020AS3) maturing August 14, 2025, with a 3.875% coupon rate, paying semi-annually, currently trading at 102.101%, minimum purchase 2000, rated A+ by S&P.